John Overington
Hoofd Techniek/Wetenschap/O&O bij EXSCIENTIA PLC
Actieve functies van John Overington
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
EXSCIENTIA PLC | Hoofd Techniek/Wetenschap/O&O | 01-05-2024 | - |
Corporate Officer/Principal | 01-07-2021 | 01-05-2024 | |
The Cambridge Crystallographic Data Centre
The Cambridge Crystallographic Data Centre Data Processing ServicesTechnology Services The Cambridge Crystallographic Data Centre, founded in 1965, is a non-profit company that specializes in providing support and licensing for their CSD data and software. The company is based in Cambridge, UK and has subsidiaries in the United Kingdom. The British company's historical structures date back to the 1920s. The CS-Crossminer software allows users to build pharmacophore queries and mine the CS data simultaneously. | Directeur/Bestuurslid | - | - |
Loopbaan van John Overington
Eerdere bekende functies van John Overington
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 01-01-1992 | - |
Medicines Discovery Catapult Ltd.
Medicines Discovery Catapult Ltd. Miscellaneous Commercial ServicesCommercial Services Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy. | Hoofd Techniek/Wetenschap/O&O | - | - |
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | 01-01-2000 | - |
Opleiding van John Overington
University of Bath | Undergraduate Degree |
Birkbeck University of London | Doctorate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 7 |
Verenigde Staten | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PFIZER, INC. | Health Technology |
EXSCIENTIA PLC | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
The Cambridge Crystallographic Data Centre
The Cambridge Crystallographic Data Centre Data Processing ServicesTechnology Services The Cambridge Crystallographic Data Centre, founded in 1965, is a non-profit company that specializes in providing support and licensing for their CSD data and software. The company is based in Cambridge, UK and has subsidiaries in the United Kingdom. The British company's historical structures date back to the 1920s. The CS-Crossminer software allows users to build pharmacophore queries and mine the CS data simultaneously. | Technology Services |
Medicines Discovery Catapult Ltd.
Medicines Discovery Catapult Ltd. Miscellaneous Commercial ServicesCommercial Services Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy. | Commercial Services |
- Beurs
- Insiders
- John Overington
- Ervaring